Skyrizi — Nutrient Associations & Health Patterns
Also known as: Risankizumab-rzaa
Drug Class: Biologic Immunosuppressant (IL-23 Inhibitor)
Skyrizi is a Biologic Immunosuppressant (IL-23 Inhibitor) that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Skyrizi.
Common Side Effects of Skyrizi
- Upper respiratory infections
- Headache
- Fatigue
- Injection site reactions
- Fungal infections
- TB reactivation risk
Key Drug Interactions — Skyrizi
Skyrizi has 3 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Live vaccines (AVOID)
- Other immunosuppressants
- Immunizations
Frequently Asked Questions
What nutrient associations are reported for Skyrizi?
Skyrizi may affect nutrient status or timing in some contexts. WePattern maps evidence-qualified relationships, not a diagnosis or a guaranteed depletion.
Which nutrient relationships are mapped for Skyrizi?
WePattern maps the documented nutrient connections for Skyrizi drawn from clinical literature, where available.
What are the side effects of Skyrizi?
Common side effects associated with Skyrizi include: Upper respiratory infections; Headache; Fatigue; Injection site reactions; Fungal infections.